Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01809704 · ClinicalTrials.gov registry record
Clinical Validation of New OCT System
A clinical trial, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 87
- Enrollment target
NCT01809704: Completed study, sponsored by Topcon Medical Systems.
NCT01809704 is a clinical trial that has completed, run by Topcon Medical Systems. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01809704 has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 87 participants
- Enrollment target
Study Summary
To demonstrate clinical substantial equivalence of DRI OCT-1 as comparable to the commercially available Cirrus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2013-02-25 |
| Est. Completion | 2013-07-03 |
What the finished NCT01809704 record still lists
NCT01809704 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 87 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01809704 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01809704 about?
NCT01809704 is a clinical study titled "Clinical Validation of New OCT System". To demonstrate clinical substantial equivalence of DRI OCT-1 as comparable to the commercially available Cirrus
What is the current status of trial NCT01809704?
This trial is currently completed. The enrollment target is 87 participants. The study started on 2013-02-25. Estimated completion is 2013-07-03.
Who is sponsoring clinical trial NCT01809704?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI